Ceftaroline-resistant, daptomycin-tolerant, and heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus causing infective endocarditis

Masayuki Nigo; Lorena Diaz; Lina P. Carvajal; Truc T. Tran; Rafael Rios; Diana Panesso; Juan D. Garavito; William R. Miller; Audrey Wanger; George Weinstock; Jose M. Munita; Cesar A. Arias; Henry F. Chambers

doi:10.1128/AAC.01235-16

Ceftaroline-resistant, daptomycin-tolerant, and heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus causing infective endocarditis

Masayuki Nigo, Lorena Diaz, Lina P. Carvajal, Truc T. Tran, Rafael Rios, Diana Panesso, Juan D. Garavito, William R. Miller, Audrey Wanger, George Weinstock, Jose M. Munita, Cesar A. Arias, Henry F. Chambers

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Abstract

We report a case of infective endocarditis (IE) caused by ceftaroline-resistant, daptomycin-tolerant, and heterogeneous vancomycin-intermediate methicillin-resistant S. aureus (MRSA). Resistance to ceftaroline emerged in the absence of drug exposure, and the E447K substitution in the active site of PBP2a previously associated with ceftaroline resistance was identified. Additionally, we present evidence of patient-to-patient transmission of the strain within the same unit. This case illustrates the difficulties in treating MRSA IE in the setting of a multidrug-resistant phenotype.

Original language	English (US)
Article number	e01235
Journal	Antimicrobial Agents and Chemotherapy
Volume	61
Issue number	3
DOIs	https://doi.org/10.1128/AAC.01235-16
State	Published - Mar 1 2017

Keywords

Ceftaroline
Endocarditis
Staphylococcus aureus

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)
Infectious Diseases

Access to Document

10.1128/AAC.01235-16

Cite this

Nigo, M., Diaz, L., Carvajal, L. P., Tran, T. T., Rios, R., Panesso, D., Garavito, J. D., Miller, W. R., Wanger, A., Weinstock, G., Munita, J. M., Arias, C. A., & Chambers, H. F. (2017). Ceftaroline-resistant, daptomycin-tolerant, and heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus causing infective endocarditis. Antimicrobial Agents and Chemotherapy, 61(3), Article e01235. https://doi.org/10.1128/AAC.01235-16

Nigo, M, Diaz, L, Carvajal, LP, Tran, TT, Rios, R, Panesso, D, Garavito, JD, Miller, WR, Wanger, A, Weinstock, G, Munita, JM, Arias, CA & Chambers, HF 2017, 'Ceftaroline-resistant, daptomycin-tolerant, and heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus causing infective endocarditis', Antimicrobial Agents and Chemotherapy, vol. 61, no. 3, e01235. https://doi.org/10.1128/AAC.01235-16

@article{7e219709a4b14c8d93998fe0756b62a7,

title = "Ceftaroline-resistant, daptomycin-tolerant, and heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus causing infective endocarditis",

abstract = "We report a case of infective endocarditis (IE) caused by ceftaroline-resistant, daptomycin-tolerant, and heterogeneous vancomycin-intermediate methicillin-resistant S. aureus (MRSA). Resistance to ceftaroline emerged in the absence of drug exposure, and the E447K substitution in the active site of PBP2a previously associated with ceftaroline resistance was identified. Additionally, we present evidence of patient-to-patient transmission of the strain within the same unit. This case illustrates the difficulties in treating MRSA IE in the setting of a multidrug-resistant phenotype.",

keywords = "Ceftaroline, Endocarditis, Staphylococcus aureus",

author = "Masayuki Nigo and Lorena Diaz and Carvajal, {Lina P.} and Tran, {Truc T.} and Rafael Rios and Diana Panesso and Garavito, {Juan D.} and Miller, {William R.} and Audrey Wanger and George Weinstock and Munita, {Jose M.} and Arias, {Cesar A.} and Chambers, {Henry F.}",

year = "2017",

month = mar,

day = "1",

doi = "10.1128/AAC.01235-16",

language = "English (US)",

volume = "61",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "3",

}

TY - JOUR

T1 - Ceftaroline-resistant, daptomycin-tolerant, and heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus causing infective endocarditis

AU - Nigo, Masayuki

AU - Diaz, Lorena

AU - Carvajal, Lina P.

AU - Tran, Truc T.

AU - Rios, Rafael

AU - Panesso, Diana

AU - Garavito, Juan D.

AU - Miller, William R.

AU - Wanger, Audrey

AU - Weinstock, George

AU - Munita, Jose M.

AU - Arias, Cesar A.

AU - Chambers, Henry F.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - We report a case of infective endocarditis (IE) caused by ceftaroline-resistant, daptomycin-tolerant, and heterogeneous vancomycin-intermediate methicillin-resistant S. aureus (MRSA). Resistance to ceftaroline emerged in the absence of drug exposure, and the E447K substitution in the active site of PBP2a previously associated with ceftaroline resistance was identified. Additionally, we present evidence of patient-to-patient transmission of the strain within the same unit. This case illustrates the difficulties in treating MRSA IE in the setting of a multidrug-resistant phenotype.

AB - We report a case of infective endocarditis (IE) caused by ceftaroline-resistant, daptomycin-tolerant, and heterogeneous vancomycin-intermediate methicillin-resistant S. aureus (MRSA). Resistance to ceftaroline emerged in the absence of drug exposure, and the E447K substitution in the active site of PBP2a previously associated with ceftaroline resistance was identified. Additionally, we present evidence of patient-to-patient transmission of the strain within the same unit. This case illustrates the difficulties in treating MRSA IE in the setting of a multidrug-resistant phenotype.

KW - Ceftaroline

KW - Endocarditis

KW - Staphylococcus aureus

UR - http://www.scopus.com/inward/record.url?scp=85014066977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014066977&partnerID=8YFLogxK

U2 - 10.1128/AAC.01235-16

DO - 10.1128/AAC.01235-16

M3 - Article

C2 - 28232309

AN - SCOPUS:85014066977

SN - 0066-4804

VL - 61

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

IS - 3

M1 - e01235

ER -

Ceftaroline-resistant, daptomycin-tolerant, and heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus causing infective endocarditis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this